Logo

Gregory Schiffman

Oct 05, 2016

Lion Biotechnologies has appointed Gregory Schiffman as CFO. Schiffman brings fifteen years of experience holding leadership roles in financial operations and strategy in publicly-traded healthcare companies, such as Dendreon, Affymetrix, and Applied Biosystems. Most recently, he served as executive vice president and CFO of StemCells. Prior to StemCells, Schiffman served as executive vice president and CFO of Dendron. Before his work in the healthcare industry, he held roles of increasing responsibility at Hewlett Packard, including serving as controller of its European personal computer manufacturing and distribution operations in Grenoble, France, and as manufacturing and controller of its Netmetrix division.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.